Total Valuation
Amarantus Biosci has a market cap or net worth of $630.00. The enterprise value is $19.18M.
Market Cap$630.00
Enterprise Value$19.18M
Share Statistics
Amarantus Biosci has 630,407,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding630,407,400
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Amarantus Biosci’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 4.85%.
Return on Equity (ROE)0.19
Return on Assets (ROA)-0.47
Return on Invested Capital (ROIC)4.85%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee7.94K
Profits Per Employee-396.86K
Employee Count12
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Amarantus Biosci is ―. Amarantus Biosci’s PEG ratio is 0.00331.
PE Ratio―
PS Ratio10.34
PB Ratio-0.04
Price to Fair Value-0.04
Price to FCF-0.22
Price to Operating Cash Flow-0.01
PEG Ratio0.00331
Income Statement
In the last 12 months, Amarantus Biosci had revenue of 95.33K and earned -4.76M in profits. Earnings per share was -0.01.
Revenue95.33K
Gross Profit95.33K
Operating Income-268.00K
Pretax Income-4.76M
Net Income-4.76M
EBITDA-4.53M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -1.49M and capital expenditures 0.00, giving a free cash flow of -1.49M billion.
Operating Cash Flow-1.49M
Free Cash Flow-1.49M
Free Cash Flow per Share>-0.01
Dividends & Yields
Amarantus Biosci pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta139.14
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)―
Important Dates
Amarantus Biosci upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Amarantus Biosci as a current ratio of <0.01, with Debt / Equity ratio of -77.60%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap19.42
Net Debt to EBITDA-4.22
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Amarantus Biosci has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Amarantus Biosci EV to EBITDA ratio is -4.44, with an EV/FCF ratio of -4.47.
EV to Sales211.10
EV to EBITDA-4.44
EV to Free Cash Flow-4.47
EV to Operating Cash Flow-4.47
Balance Sheet
Amarantus Biosci has $0.00 in cash and marketable securities with $19.12M in debt, giving a net cash position of -$19.12M billion.
Cash & Marketable Securities$0.00
Total Debt$19.12M
Net Cash-$19.12M
Net Cash Per Share-$0.03
Tangible Book Value Per Share-$0.04
Margins
Gross margin is 100.00%, with operating margin of -281.13%, and net profit margin of -4995.23%.
Gross Margin100.00%
Operating Margin-281.13%
Pretax Margin-4995.23%
Net Profit Margin-4995.23%
EBITDA Margin-4755.55%
EBIT Margin-4995.23%
Analyst Forecast
The average price target for Amarantus Biosci is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―